.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Queensland Health
Novartis
Teva
QuintilesIMS
Merck
Healthtrust
Chinese Patent Office
US Army
Johnson and Johnson

Generated: December 18, 2017

DrugPatentWatch Database Preview

DEFEROXAMINE MESYLATE Drug Profile

« Back to Dashboard

When do Deferoxamine Mesylate patents expire, and when can generic versions of Deferoxamine Mesylate launch?

Deferoxamine Mesylate is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Watson Labs, and West-ward Pharms Int. and is included in five NDAs.

The generic ingredient in DEFEROXAMINE MESYLATE is deferoxamine mesylate. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
Drug patent expirations by year for DEFEROXAMINE MESYLATE

Pharmacology for DEFEROXAMINE MESYLATE

Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity

Medical Subject Heading (MeSH) Categories for DEFEROXAMINE MESYLATE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi UsaDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION078718-002Sep 15, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Watson LabsDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION076806-002Mar 31, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Gland Pharma LtdDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION207384-001Sep 29, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Watson LabsDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION076806-001Mar 31, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION078718-001Sep 15, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Gland Pharma LtdDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION207384-002Sep 29, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
HospiraDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION076019-001Mar 17, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
HospiraDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION076019-002Mar 17, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION078086-001May 30, 2007APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION078086-002May 30, 2007APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Moodys
Covington
Healthtrust
Teva
QuintilesIMS
Baxter
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot